CIBC Asset Management Inc Acquires 35,898 Shares of Synopsys, Inc. $SNPS

CIBC Asset Management Inc boosted its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 75.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 83,511 shares of the semiconductor company’s stock after purchasing an additional 35,898 shares during the quarter. CIBC Asset Management Inc’s holdings in Synopsys were worth $41,203,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Alpine Bank Wealth Management increased its stake in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after acquiring an additional 25 shares in the last quarter. TFC Financial Management Inc. grew its holdings in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC acquired a new stake in Synopsys in the third quarter worth $27,000. Independence Bank of Kentucky increased its stake in Synopsys by 120.0% in the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 30 shares in the last quarter. Finally, SOA Wealth Advisors LLC. acquired a new position in shares of Synopsys during the third quarter valued at about $28,000. 85.47% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Thursday. Citigroup initiated coverage on Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective for the company. BNP Paribas Exane started coverage on Synopsys in a research report on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price on the stock. KeyCorp lifted their price target on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Finally, Morgan Stanley boosted their price target on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and an average price target of $553.57.

View Our Latest Stock Report on Synopsys

Insider Activity at Synopsys

In other news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 4,157 shares of company stock worth $1,945,036. Insiders own 0.62% of the company’s stock.

Synopsys Trading Down 1.6%

Shares of Synopsys stock opened at $501.39 on Monday. The company has a market capitalization of $95.93 billion, a P/E ratio of 62.75, a price-to-earnings-growth ratio of 4.17 and a beta of 1.12. The stock has a fifty day simple moving average of $466.97 and a 200 day simple moving average of $503.61. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business’s revenue for the quarter was up 37.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.